SONA Share Price Performance
Recent SONA News & Updates
No updates
Sona Nanotech Inc. Key Details
Last Reported Earnings
Apr 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.026
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 41.7%
Sona Nanotech Inc. Competitors
About SONA
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests. Sona Nanotech Inc. is based in Halifax, Canada.
Canadian Market Performance
- 7 Days: 0.9%
- 3 Months: 11.0%
- 1 Year: 18.4%
- Year to Date: 10.4%
In the last week, the market has been flat, with a notable exception in the Industrials sector dropping 3.1%. Meanwhile, the market is actually up 18% over the past year. Earnings are forecast to grow by 12% annually. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
Continue readingLast Week
